Both in vitro and in vivo experiments confirmed the original hypothesis that the overexpression of CXCR5 improves the migration of CAR-T cells to the CXCL13-positive tumor site, as shown directly by tracking CAR-T cells in vivo. Here, CXCR5 is linked to neoplasm.